SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 57.7. According to RSI analysis, sunpharma is strong. 7.0 SUNPHARMA RSI Chart
MACD (?) MACD: 6.76 and Signal Line: 4.11. According to MACD analysis, sunpharma is technically strong. 8.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance from it's 200-day simple moving average at 728.6285 and support level is at 655. 7.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is facing resistance from it's 200-day exponential moving average at 717.1882 and support level is at 658. 7.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.787. According to bollinger bands, sunpharma is technically strong. 7.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 17.5 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 15.4 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 23, 2017
Open Price 673.9
High Price 681.3
Low Price 667.05
Close Price 674.55
Absolute Change 4.2
Percentage Change 0.627%
Weekly Change 3.89%
Monthly Change 6.09%
Yearly Change -21.2%
52-week high 898.45
52-week low 571.9
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.595
Confidence in Beta1.82%
Market Capital Rs. 162344.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 75.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 February 2017: Deliverable Quantity:2.76e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 February 2017: Daily Volatility:0.3725 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 February 2017: PCR_OI:0.547 PCR:0.358 NA SUNPHARMA PCR Chart
Premium (?) 23 February 2017 Premium: 0.7 Futures OI:4461100.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 23 February 2017: Price:674.55 Put with maximum OI:600.0 Call with maximum OI:700.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
February 23, 2017 675.25 4461100.0 11909.0 18687.0 674.55
March 30, 2017 677.05 28488600.0 11829.0 18770.0 674.55
April 27, 2017 681.1 109900.0 80.0 82.0 674.55

Option Chains - NSE

SUNPHARMA Option Zone

Announcements

February 14, 2017 SAllotment of SecuritiesSun Pharmaceuticals Industries Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on February 14, 2017, allotted 20,993(Twenty Thousand Nine Hundred and Ninety Three) equity shares of the Company of Re. 1/- (Rupee One Only) each, on exercise of stock options under the Sun Employee Stock Option Scheme - 2015. Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs. 2,39,92,91,181/- (Rupees Two Hundred and Thirty Nine Crore Ninety Two Lakhs Ninety One Thousand One Hundred and Eighty One Only) divided into 2,39,92,91,181/- (Two Hundred and Thirty Nine Crore Ninety Two Lakhs Ninety One Thousand One Hundred and Eighty One Only) equity shares of Re.1/- each.
February 14, 2017 SOutcome of Board MeetingSun Pharmaceuticals Industries Limited has informed the Exchange regarding the outcome of Board Meeting held on February 14, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 25, 2016 November 10, 2016 TResults/OthersTo transact, interalia, the following business:
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY 1.88
CNX100 1.6
CNX500 1.34
CNXPHARMA 26.08

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 653 Rs. 660 Rs. 667.3 Rs. 674.3 Rs. 681.5 Rs. 688.5 Rs. 695.8